Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.VBI Vaccines announces second pivotal phase 3 study of Sci-B-Vac meets primary and secondary endpoints
VBI Vaccines announces second pivotal phase 3 study of Sci-B-Vac meets primary and secondary endpoints. (Credit: Arek Socha from Pixabay)
VBI Vaccines announces second pivotal phase 3 study of Sci-B-Vac meets primary and secondary endpoints. (Credit: Arek Socha from Pixabay)